Based on 19 studies providing data on CYP1A2 rs762551 polymorphism and cancer risk, we conduced a meta-analysis involving in 8218 cancer cases and 11165 controls to indicate if the rs762551 polymorphism was significantly associated with risk of cancer. The gene discussed is CYP1A2; the disease is cancer.